Research Funding

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

 

Cellular Senescence Network (SenNet)

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date
Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed) 10/27/2021 RFA-RM-22-003
Viviana Perez
viviana.perezmontes@nih.gov
240-328-7301
Letters of Intent:
12/20/2021
Receipt Date:
01/19/2021

 
Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) 10/28/2021 RFA-RM-22-004 Chamelli Jhappan
jhappanc@nih.gov
240-276-6200
Letter of Intent:
12/20/2021
Receipt Date:
01/18/2021
Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) 10/28/2021 RFA-RM-22-005 Chamelli Jhappan
jhappanc@nih.gov
240-276-6200
Letter of Intent:
12/20/2021
Receipt Date:
01/19/2021

 

Stimulating Peripheral Activity to Relieve Conditions Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

SPARC Human Open Research Neural Engineering Technologies (HORNET) Initiative (U41 Clinical Trial Not Allowed)

10/6/2021 RFA-RM-21-024 SPARC-O@od.nih.gov Letter of Intent:
30 days prior to the application due date
Receipt Date:
1/12/2022

Gabriella Miller Kids First Pediatric Research Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) 11/2/2021 PAR-22-054

James Coulombe
coulombej@mail.nih.gov
301-451-1390

Huiqing Li
huiqing.li@nih.gov
301-435-0554

Lu Wang
wanglu@mail.nih.gov
301-594-4846

Malcolm A. Smith
Malcolm.Smith@nih.gov
240-276-6087

Jaime M. Guidry Auvil
jaime.guidryauvil@nih.gov
240-781-3307

Letter of Intent:
30 days prior to the application due date
Receipt Date:
2/23/2022

Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)

11/17/2021 RFA-RM-22-006 James Coulombe
coulombej@mail.nih.gov
301-451-1390
Letter of Intent:
5/10/2022
Receipt Date:
6/10/2022

 

Past Funding Opportunities

This page last reviewed on December 6, 2021